A stress and coping model of medication adherence and viral load in HIV-positive men and women on highly active antiretroviral therapy (HAART)

Health Psychology

Volumn 24, Issue 4, 2005, Pages 385-392

  Weaver, Kathryn E ^a,b   Llabre, María M ^a,b   Durán, Ron E ^a,b   Antoni, Michael H ^a,b   Ironson, Gail ^a,b   Penedo, Frank J ^a,b   Schneiderman, Neil ^a,b  

^a UNIVERSITY OF MIAMI   (United States)

^b Department of Biology   (United States)

Author keywords

Adherence; Antiretroviral therapy; Avoidance oriented coping; HIV; Social support

Indexed keywords

ADULT; AGE; ARTICLE; AVOIDANCE BEHAVIOR; COPING BEHAVIOR; DISEASE COURSE; DISEASE DURATION; ELECTRONIC MONITORING; ELECTRONICS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MODEL; MOOD; NEGATIVE MOOD; PATIENT COMPLIANCE; PATIENT MONITORING; SELF REPORT; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; STRESS; STRUCTURAL MODEL; VIRUS LOAD;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; FLORIDA; HIV SEROPOSITIVITY; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MODELS, THEORETICAL; PATIENT COMPLIANCE; SOCIAL SUPPORT; VIRAL LOAD;

EID: 23244459462     PISSN: 02786133     EISSN: None     Source Type: Journal    
DOI: 10.1037/0278-6133.24.4.385     Document Type: Article

References (40)

1. Ammassari, A., Murri, R., Pezzotti, P., Paola Trotta, M., Ravasio, L., De Longis, P., et al. (2001). Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV-infection. Journal of Acquired Immune Deficiency Syndromes, 28, 445-449.
2. Anderson, J. C., & Gerbing, D. W. (1988). Structural equation modeling in practice: A review and recommended two-step approach. Psychological Bulletin, 103, 411-423.
3. Aspinwall, L. G., & Taylor, S. E. (1992). Modeling cognitive adaptation: A longitudinal investigation of the impact of individual difference and coping on college adjustment and performance. Journal of Personality and Social Psychology, 63, 989-1003.
4. Baron, R. M., & Kenny, D. A. (1986). The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 51, 1173-1182.
5. Carver, C. S., Scheier, M. F., & Weintraub, J. K. (1989). Assessing coping strategies: A theoretically based approach. Journal of Personality and Social Psychology, 56, 267-283.
6. Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., & McAuliffe, T. L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124-133.
7. Centers for Disease Control and Prevention. (2003). HIV/AIDS surveillance report 2002. Atlanta, GA: Author.
8. Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care, 12, 255-266.
9. Chesney, M. A., Morin, M., & Sherr, L. (2000). Adherence to HIV combination therapy. Social Science & Medicine, 50, 1599-1605.
10. Cohen, S., & Hoberman, H. M. (1983). Positive events and social support as buffers of life change stress. Journal of Applied Social Psychology, 13, 99-125.
11. Cutrona, C. E., & Russell, D. (1987). The provisions of social relationships and adaptation to stress. In W. H. Jones & D. Perlman (Eds.), Advances in personal relationships (pp. 37-68). Greenwich, CT: JAI Press.
12. DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effect of anxiety and depression on patient adherence. Archives of Internal Medicine, 160, 2101-2107.
13. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1997). Structured Clinical Interview for DSM-IV Axis I Disorders-Non-patient edition (SCID-IV/NP; Version 2.0). New York: Biometrics Research Department, NY State Psychiatric Institute.
14. Gonzalez, J. S., Penedo, F. J., Antoni, M. H., Durán, R. E., Fernandez, M. I., McPherson-Baker, S., et al. (2004). Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychology, 23, 413-418.
15. Hamilton, A. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56-61.
16. Heaney, C. A., & Israel, B. A. (1997). Social networks and social support. In K. Glanz, F. Marcus Lewis, & B. K. Rimer (Eds.), Health behavior and health education: Theory, research, and practice (2nd ed., pp. 179-205). San Francisco: Jossey-Bass.
17. Holzemer, W. L., Corless, I. B., Nokes, K. M., Turner, J. G., Brown, M. A., Powell-Cope, G. M., et al. (1999). Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care and STDs, 13, 185-197.
18. Howard, A. A., Arnsten, J. H., Lo, Y., Vlahov, D., Rich, J. D., Schuman, P., et al. (2002). A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS, 16, 2175-2182.
19. Hu, L., & Bentler, P. M. (1999). Cutoff criteria for fit indices in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling, 6, 1-55.
20. Isen, A. M. (1984). Toward understanding the role of affect in cognition. In R. S. Wyer & T. K. Srull (Eds.), Handbook of social cognitions (pp. 179-236). Hillsdale, NJ: Erlbaum.
21. Lazarus, R. S., & Folkman, S. (1984). Stress, appraisal, and coping. New York: Springer Publishing Company.
22. Manfredi, R., & Chiodo, F. (2001). Switch of protease inhibitor-containing HAART in routine clinical practice: A four-year prospective observational study. International Journal of STD and AIDS, 12, 84-88.
23. McNair, D. M., Lorr, M., & Droppleman, L. F. (1981). Profile of mood states manual. San Diego, CA: EdITS.
24. Miami-Dade County Health Department. (2003). MDCHD-HIV/AIDS surveillance. Retrieved January 31, 2004, from http://www.dadehealth.org/ downloads/HIV_AIDS_2000-2002.pdf
25. Muthén, L. K., & Muthén, B. O. (1998). Mplus user's guide. Los Angeles: Muthén & Muthén.
26. Nieuwkerk, P. T., Gisolf, E. H., Reijers, M. H., Lange, J. M., Danner, S. A., & Spranger, M. A. (2001). Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection. AIDS, 15, 1985-1991.
27. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
28. Penedo, F. J., Gonzalez, J. S., Davis, C., Dann, J., Antoni, M. H., Ironson, G., et al. (2003). Coping and psychological distress among symptomatic HIV+ men who have sex with men. Annals of Behavioral Medicine, 25, 203-213.
29. Perno, C. F., Ceccherini-Silberstein, F., De Luca, A., Cozzi-Lepri, A., Gori, C., Cingolani, A., et al. (2002). Virologic correlates of adherence to antiretroviral medications and therapeutic failure. Journal of Acquired Immune Deficiency Syndromes, 31, S118-S122.
30. Power, C., Selnes, O., Grim, J., & McArthur, J. (1995). HIV Dementia Scale: A rapid screening test. Journal of AIDS and Human Retroviruses, 8, 273-278.
31. Press, N., Tyndall, M. W., Wood, E., Hogg, R. S., & Montaner, J. S. G. (2002). Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence. Journal of Acquired Immune Deficiency Syndromes, 31, S112-S117.
32. Schafer, J. L., & Graham, J. W. (2002). Missing data: Our view of the state of the art. Psychological Methods, 7, 147-177.
33. Singh, N., Berman, S. M., Swindells, S., Justis, J. C., Mohr, J. A., Squier, C., et al. (1999). Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clinical Infectious Diseases, 29, 824-830.
34. Starace, R, Ammassari, A., Paola Trotta, A., Murri, R., De Longis, P., Izzo, C., et al. (2002). Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 31, S136-S139.
35. Tesoriero, J., French, T., Weiss, L., Waters, M., Finkelstein, R., & Agins, B. (2003). Stability of adherence to highly active antiretroviral therapy over time among clients enrolled in the treatment adherence demonstration project. Journal of Acquired Immune Deficiency Syndromes, 33, 484-493.
36. Thoits, P. A. (1986). Social support as coping assistance. Journal of Consulting and Clinical Psychology, 54, 416-423.
37. Touloumi, G., Paparizos, V., Sambatakou, H., Katsarou, O., Chrysos, G., Kordossis, T., et al. (2001). Virological and immunological response to HAART therapy in a community-based cohort of HIV-1 positive individuals. HIV Clinical Trials, 2, 6-16.
38. Van Vaerenbergh, K., De Geest, S., Derdelinckx, I., Bobbaers, H., Carbonez, A., Deschamps, A., et al. (2002). A combination of poor adherence and a low baseline susceptibility score is highly predictive for HAART failure. Antiviral Chemistry and Chemotherapy, 13, 231-240.
39. Wilkinson, G. S. (1993). The Wide Range Achievement Test-3rd Edition (WRAT3). Wilmington, DE: Wide Range.
40. Williams, J. (1980). Structured Interview Guide for the Hamilton Depression and Anxiety Scales (SIGH-AD). New York: Biometrics Research Department, NY State Psychiatric Institute.